Page last updated: 2024-10-24

chlorambucil and Rheumatic Heart Disease

chlorambucil has been researched along with Rheumatic Heart Disease in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Rheumatic Heart Disease: Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shakhbazian, IE1
Ulybina, OV1
Sarsembaeva, RT1
Sushkova, NI1
Rozvadovskaia, OS1
Katargina, LA1

Trials

1 trial available for chlorambucil and Rheumatic Heart Disease

ArticleYear
[Use of chlorbutin in the complex treatment of systemic forms of juvenile rheumatoid arthritis].
    Pediatriia, 1990, Issue:3

    Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Child; Child, Preschool; Chlorambucil; Cl

1990